Accessibility Menu
 
Novo Integrated Sciences logo

Novo Integrated Sciences

(OTC) NVOS

Current Price$0.00
Market Cap$69,100
Since IPO (2017)-100%
5 Year-100%
1 Year+400%
1 Month+218%

Novo Integrated Sciences Financials at a Glance

Market Cap

$69,100

Revenue (TTM)

$13.29M

Net Income (TTM)

$16.17M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-7.84 (Low)

Price

$0.00

Volume

478

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.06

NVOS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Integrated Sciences

Industry

Healthcare Providers and Services

Employees

264

CEO

Robert Mattacchione

Headquarters

Bellevue, WA 98004, US

NVOS Financials

Key Financial Metrics (TTM)

Gross Margin

43%

Operating Margin

-63%

Net Income Margin

-1%

Return on Equity

0%

Return on Capital

-47%

Return on Assets

-50%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$69.10K

Shares Outstanding

19.73M

Volume

478

Short Interest

0.00%

Avg. Volume

3.42K

Financials (TTM)

Gross Profit

$5.74M

Operating Income

$8.31M

EBITDA

$10.08M

Operating Cash Flow

$2.24M

Capital Expenditure

$49.22K

Free Cash Flow

$2.29M

Cash & ST Invst.

$844.58K

Total Debt

$4.71M

Novo Integrated Sciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$3.08M

-6.7%

Gross Profit

$1.58M

+70.0%

Gross Margin

51.21%

N/A

Market Cap

$69.10K

N/A

Market Cap/Employee

$600.87

N/A

Employees

115

N/A

Net Income

$5.00M

+258.3%

EBITDA

$7.25M

+440.7%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

$3.87M

+4.7%

Accounts Receivable

$3.15M

+114.9%

Inventory

$1.00M

-9.6%

Long Term Debt

$2.99M

+70.2%

Short Term Debt

$3.16M

+16.4%

Return on Assets

-50.18%

N/A

Return on Invested Capital

-47.34%

N/A

Free Cash Flow

$548.95K

-111.8%

Operating Cash Flow

$545.92K

-138.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BBBTBlack Bird Biotech, Inc.
$0.00+0.00%
BRAXFBraxia Scientific Corp.
$0.00+0.00%
OMHEOmni Health, Inc.
$0.00+0.00%
ACGIThe Amacore Group, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
PLTRPalantir Technologies
$128.06-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
CRWVCoreWeave
$102.00+0.11%
NOKNokia
$9.46-0.01%

Questions About NVOS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.